ID   DPOD2_HUMAN             Reviewed;         469 AA.
AC   P49005; A4D2J4; B2R5S4;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   18-JUN-2025, entry version 214.
DE   RecName: Full=DNA polymerase delta subunit 2;
DE   AltName: Full=DNA polymerase delta subunit p50;
GN   Name=POLD2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8530069; DOI=10.1006/geno.1995.1229;
RA   Zhang J., Tan C.-K., McMullen B., Downey K.M., So A.G.;
RT   "Cloning of the cDNAs for the small subunits of bovine and human DNA
RT   polymerase delta and chromosomal location of the human gene (POLD2).";
RL   Genomics 29:179-186(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10978529; DOI=10.1016/s0167-4781(00)00153-6;
RA   Perez A., Leon A., Lee M.Y.W.T.;
RT   "Characterization of the 5'-flanking region of the gene encoding the 50 kDa
RT   subunit of human DNA polymerase delta.";
RL   Biochim. Biophys. Acta 1493:231-236(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT SER-303.
RG   NIEHS SNPs program;
RL   Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S., Kwasnicka D.,
RA   Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z., Lu F., Zeesman S.,
RA   Nowaczyk M.J., Teshima I., Chitayat D., Shuman C., Weksberg R.,
RA   Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J., Rahman N.,
RA   Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F., Belloni E.,
RA   Shaffer L.G., Pober B., Morton C.C., Gusella J.F., Bruns G.A.P., Korf B.R.,
RA   Quade B.J., Ligon A.H., Ferguson H., Higgins A.W., Leach N.T.,
RA   Herrick S.R., Lemyre E., Farra C.G., Kim H.-G., Summers A.M., Gripp K.W.,
RA   Roberts W., Szatmari P., Winsor E.J.T., Grzeschik K.-H., Teebi A.,
RA   Minassian B.A., Kere J., Armengol L., Pujana M.A., Estivill X.,
RA   Wilson M.D., Koop B.F., Tosi S., Moore G.E., Boright A.P., Zlotorynski E.,
RA   Kerem B., Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W., Mural R.J.,
RA   Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INTERACTION WITH POLD1 AND POLD3.
RX   PubMed=11328591; DOI=10.1093/oxfordjournals.jbchem.a002909;
RA   Shikata K., Ohta S., Yamada K., Obuse C., Yoshikawa H., Tsurimoto T.;
RT   "The human homologue of fission Yeast cdc27, p66, is a component of active
RT   human DNA polymerase delta.";
RL   J. Biochem. 129:699-708(2001).
RN   [9]
RP   INTERACTION WITH KCTD13.
RX   PubMed=11593007; DOI=10.1073/pnas.221452098;
RA   He H., Tan C.-K., Downey K.M., So A.G.;
RT   "A tumor necrosis factor alpha- and interleukin 6-inducible protein that
RT   interacts with the small subunit of DNA polymerase delta and proliferating
RT   cell nuclear antigen.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:11979-11984(2001).
RN   [10]
RP   FUNCTION, CHARACTERIZATION OF POL-DELTA2 AND POL-DELTA4 COMPLEXES, AND LACK
RP   OF INTERACTION WITH PCNA.
RX   PubMed=12403614; DOI=10.1021/bi0262707;
RA   Xie B., Mazloum N., Liu L., Rahmeh A., Li H., Lee M.Y.;
RT   "Reconstitution and characterization of the human DNA polymerase delta
RT   four-subunit holoenzyme.";
RL   Biochemistry 41:13133-13142(2002).
RN   [11]
RP   INTERACTION WITH POLD1; POLDIP2 AND POLDIP3.
RX   PubMed=12522211; DOI=10.1074/jbc.m208694200;
RA   Liu L., Rodriguez-Belmonte E.M., Mazloum N., Xie B., Lee M.Y.W.T.;
RT   "Identification of a novel protein, PDIP38, that interacts with the p50
RT   subunit of DNA polymerase delta and proliferating cell nuclear antigen.";
RL   J. Biol. Chem. 278:10041-10047(2003).
RN   [12]
RP   INTERACTION WITH WRNIP1.
RX   PubMed=15670210; DOI=10.1111/j.1365-2443.2004.00812.x;
RA   Tsurimoto T., Shinozaki A., Yano M., Seki M., Enomoto T.;
RT   "Human Werner helicase interacting protein 1 (WRNIP1) functions as a novel
RT   modulator for DNA polymerase delta.";
RL   Genes Cells 10:13-22(2005).
RN   [13]
RP   FUNCTION, INTERACTION WITH POLD1; POLD3 AND POLD4, AND LACK OF INTERACTION
RP   WITH PCNA.
RX   PubMed=16510448; DOI=10.1074/jbc.m600322200;
RA   Li H., Xie B., Zhou Y., Rahmeh A., Trusa S., Zhang S., Gao Y., Lee E.Y.,
RA   Lee M.Y.;
RT   "Functional roles of p12, the fourth subunit of human DNA polymerase
RT   delta.";
RL   J. Biol. Chem. 281:14748-14755(2006).
RN   [14]
RP   IDENTIFICATION IN POL-DELTA COMPLEX.
RX   PubMed=17317665; DOI=10.1074/jbc.m610356200;
RA   Zhang S., Zhou Y., Trusa S., Meng X., Lee E.Y., Lee M.Y.;
RT   "A novel DNA damage response: rapid degradation of the p12 subunit of dna
RT   polymerase delta.";
RL   J. Biol. Chem. 282:15330-15340(2007).
RN   [15]
RP   FUNCTION, AND CHARACTERIZATION OF POL-DELTA3 AND POL-DELTA4.
RX   PubMed=19074196; DOI=10.1093/nar/gkn1000;
RA   Meng X., Zhou Y., Zhang S., Lee E.Y., Frick D.N., Lee M.Y.;
RT   "DNA damage alters DNA polymerase delta to a form that exhibits increased
RT   discrimination against modified template bases and mismatched primers.";
RL   Nucleic Acids Res. 37:647-657(2009).
RN   [16]
RP   FUNCTION, AND IDENTIFICATION IN POL-DELTA COMPLEX.
RX   PubMed=20334433; DOI=10.1021/bi100042b;
RA   Meng X., Zhou Y., Lee E.Y., Lee M.Y., Frick D.N.;
RT   "The p12 subunit of human polymerase delta modulates the rate and fidelity
RT   of DNA synthesis.";
RL   Biochemistry 49:3545-3554(2010).
RN   [17]
RP   FUNCTION IN NUCLEOTIDE EXCISION REPAIR.
RX   PubMed=20227374; DOI=10.1016/j.molcel.2010.02.009;
RA   Ogi T., Limsirichaikul S., Overmeer R.M., Volker M., Takenaka K.,
RA   Cloney R., Nakazawa Y., Niimi A., Miki Y., Jaspers N.G., Mullenders L.H.,
RA   Yamashita S., Fousteri M.I., Lehmann A.R.;
RT   "Three DNA polymerases, recruited by different mechanisms, carry out NER
RT   repair synthesis in human cells.";
RL   Mol. Cell 37:714-727(2010).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-15, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   SUBCELLULAR LOCATION, IDENTIFICATION IN POL-DELTA COMPLEX, AND
RP   DEVELOPMENTAL STAGE.
RX   PubMed=22801543; DOI=10.4161/cc.21280;
RA   Chea J., Zhang S., Zhao H., Zhang Z., Lee E.Y., Darzynkiewicz Z., Lee M.Y.;
RT   "Spatiotemporal recruitment of human DNA polymerase delta to sites of UV
RT   damage.";
RL   Cell Cycle 11:2885-2895(2012).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [22]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [23]
RP   FUNCTION IN OKAZAKI FRAGMENT PROCESSING.
RX   PubMed=24035200; DOI=10.1016/j.dnarep.2013.08.008;
RA   Lin S.H., Wang X., Zhang S., Zhang Z., Lee E.Y., Lee M.Y.;
RT   "Dynamics of enzymatic interactions during short flap human Okazaki
RT   fragment processing by two forms of human DNA polymerase delta.";
RL   DNA Repair 12:922-935(2013).
RN   [24]
RP   POL-DELTA3 COMPLEX EXPRESSION DURING CELL CYCLE.
RX   PubMed=23913683; DOI=10.1074/jbc.m113.490466;
RA   Zhang S., Zhao H., Darzynkiewicz Z., Zhou P., Zhang Z., Lee E.Y., Lee M.Y.;
RT   "A novel function of CRL4(Cdt2): regulation of the subunit structure of DNA
RT   polymerase delta in response to DNA damage and during the S phase.";
RL   J. Biol. Chem. 288:29550-29561(2013).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-15 AND SER-257, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [26]
RP   FUNCTION, IDENTIFICATION IN POL-DELTA COMPLEX, AND IDENTIFICATION IN
RP   POL-ZETA COMPLEX.
RX   PubMed=24449906; DOI=10.1073/pnas.1324001111;
RA   Lee Y.S., Gregory M.T., Yang W.;
RT   "Human Pol zeta purified with accessory subunits is active in translesion
RT   DNA synthesis and complements Pol eta in cisplatin bypass.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:2954-2959(2014).
RN   [27]
RP   FUNCTION IN BIR.
RX   PubMed=24310611; DOI=10.1126/science.1243211;
RA   Costantino L., Sotiriou S.K., Rantala J.K., Magin S., Mladenov E.,
RA   Helleday T., Haber J.E., Iliakis G., Kallioniemi O.P., Halazonetis T.D.;
RT   "Break-induced replication repair of damaged forks induces genomic
RT   duplications in human cells.";
RL   Science 343:88-91(2014).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) IN COMPLEX WITH POLD3, AND
RP   MUTAGENESIS OF LEU-217; GLY-224 AND GLU-231.
RX   PubMed=18818516; DOI=10.4161/cc.7.19.6720;
RA   Baranovskiy A.G., Babayeva N.D., Liston V.G., Rogozin I.B., Koonin E.V.,
RA   Pavlov Y.I., Vassylyev D.G., Tahirov T.H.;
RT   "X-ray structure of the complex of regulatory subunits of human DNA
RT   polymerase delta.";
RL   Cell Cycle 7:3026-3036(2008).
RN   [29]
RP   VARIANT ASN-293, CHARACTERIZATION OF VARIANT ASN-293, AND INTERACTION WITH
RP   POLD1 AND POLD3.
RX   PubMed=31449058; DOI=10.1172/jci128903;
RA   Conde C.D., Petronczki O.Y., Baris S., Willmann K.L., Girardi E.,
RA   Salzer E., Weitzer S., Ardy R.C., Krolo A., Ijspeert H., Kiykim A.,
RA   Karakoc-Aydiner E., Foerster-Waldl E., Kager L., Pickl W.F.,
RA   Superti-Furga G., Martinez J., Loizou J.I., Ozen A., van der Burg M.,
RA   Boztug K.;
RT   "Polymerase delta deficiency causes syndromic immunodeficiency with
RT   replicative stress.";
RL   J. Clin. Invest. 129:4194-4206(2019).
CC   -!- FUNCTION: Accessory component of both the DNA polymerase delta complex
CC       and the DNA polymerase zeta complex (PubMed:17317665, PubMed:22801543,
CC       PubMed:24449906). As a component of the trimeric and tetrameric DNA
CC       polymerase delta complexes (Pol-delta3 and Pol-delta4, respectively),
CC       plays a role in high fidelity genome replication, including in lagging
CC       strand synthesis, and repair (PubMed:12403614, PubMed:16510448,
CC       PubMed:19074196, PubMed:20334433, PubMed:24035200). Pol-delta3 and Pol-
CC       delta4 are characterized by the absence or the presence of POLD4. They
CC       exhibit differences in catalytic activity. Most notably, Pol-delta3
CC       shows higher proofreading activity than Pol-delta4 (PubMed:19074196,
CC       PubMed:20334433). Although both Pol-delta3 and Pol-delta4 process
CC       Okazaki fragments in vitro, Pol-delta3 may also be better suited to
CC       fulfill this task, exhibiting near-absence of strand displacement
CC       activity compared to Pol-delta4 and stalling on encounter with the 5'-
CC       blocking oligonucleotides. Pol-delta3 idling process may avoid the
CC       formation of a gap, while maintaining a nick that can be readily
CC       ligated (PubMed:24035200). Along with DNA polymerase kappa, DNA
CC       polymerase delta carries out approximately half of nucleotide excision
CC       repair (NER) synthesis following UV irradiation (PubMed:20227374).
CC       Under conditions of DNA replication stress, required for the repair of
CC       broken replication forks through break-induced replication (BIR)
CC       (PubMed:24310611). Involved in the translesion synthesis (TLS) of
CC       templates carrying O6-methylguanine or abasic sites performed by Pol-
CC       delta4, independently of DNA polymerase zeta (REV3L) or eta (POLH).
CC       Facilitates abasic site bypass by DNA polymerase delta by promoting
CC       extension from the nucleotide inserted opposite the lesion. Also
CC       involved in TLS as a component of the DNA polymerase zeta complex
CC       (PubMed:24449906). Along with POLD3, dramatically increases the
CC       efficiency and processivity of DNA synthesis of the DNA polymerase zeta
CC       complex compared to the minimal zeta complex, consisting of only REV3L
CC       and REV7 (PubMed:24449906). {ECO:0000269|PubMed:12403614,
CC       ECO:0000269|PubMed:16510448, ECO:0000269|PubMed:19074196,
CC       ECO:0000269|PubMed:20227374, ECO:0000269|PubMed:20334433,
CC       ECO:0000269|PubMed:24035200, ECO:0000269|PubMed:24310611,
CC       ECO:0000269|PubMed:24449906}.
CC   -!- SUBUNIT: Component of both the DNA polymerase delta and DNA polymerase
CC       zeta complexes (PubMed:17317665, PubMed:22801543, PubMed:24449906,
CC       PubMed:31449058). Component of the tetrameric DNA polymerase delta
CC       complex (Pol-delta4), which consists of POLD1/p125, POLD2/p50,
CC       POLD3/p66/p68 and POLD4/p12, with POLD1 bearing DNA polymerase and 3'
CC       to 5' proofreading exonuclease activities (PubMed:17317665,
CC       PubMed:22801543). Within Pol-delta4, directly interacts with POLD1,
CC       POLD3 and POLD4 (PubMed:11328591, PubMed:16510448). Following stress
CC       caused by DNA damaging agents or by replication stress, POLD4 is
CC       degraded and Pol-delta4 is converted into a trimeric form of the
CC       complex (Pol-delta3), which consists of POLD1, POLD2 and POLD3. Pol-
CC       delta3 is the major form occurring at S phase replication sites, as
CC       well as DNA damage sites (PubMed:17317665, PubMed:22801543). Also
CC       observed as a dimeric complex with POLD2 (Pol-delta2 complex). Pol-
CC       delta2 is relatively insensitive to the PCNA stimulation (2-5-fold)
CC       compared to Pol-delta4 that is stimulated by over 50-fold
CC       (PubMed:12403614). Contrary to the other components of Pol-delta4, does
CC       not directly interact with PCNA (PubMed:12403614, PubMed:16510448). As
CC       POLD1 and POLD4, directly interacts with WRNIP1; this interaction
CC       stimulates DNA polymerase delta-mediated DNA synthesis, independently
CC       of the presence of PCNA. This stimulation may be due predominantly to
CC       an increase of initiation frequency and also to increased processivity
CC       (PubMed:15670210). Directly interacts with POLDIP2 and POLDIP3
CC       (PubMed:12522211). Directly interacts with KCTD13/PDIP1; in the
CC       presence of PCNA, this interaction may stimulate DNA polymerase
CC       activity (PubMed:11593007). Component of the tetrameric Pol-zeta
CC       complex (Pol-zeta4), which consists of REV3L, MAD2L2, POLD2 and POLD3,
CC       with REV3L bearing DNA polymerase catalytic activity (PubMed:24449906).
CC       Interacts with KCTD10 (By similarity). {ECO:0000250|UniProtKB:Q6AXY4,
CC       ECO:0000269|PubMed:11328591, ECO:0000269|PubMed:11593007,
CC       ECO:0000269|PubMed:12403614, ECO:0000269|PubMed:12522211,
CC       ECO:0000269|PubMed:15670210, ECO:0000269|PubMed:16510448,
CC       ECO:0000269|PubMed:17317665, ECO:0000269|PubMed:22801543,
CC       ECO:0000269|PubMed:24449906, ECO:0000269|PubMed:31449058}.
CC   -!- INTERACTION:
CC       P49005; P12004: PCNA; NbExp=3; IntAct=EBI-372354, EBI-358311;
CC       P49005; P28340: POLD1; NbExp=16; IntAct=EBI-372354, EBI-716569;
CC       P49005; Q15054: POLD3; NbExp=11; IntAct=EBI-372354, EBI-864956;
CC       P49005; Q9HCU8: POLD4; NbExp=7; IntAct=EBI-372354, EBI-864968;
CC       P49005; Q96S55: WRNIP1; NbExp=2; IntAct=EBI-372354, EBI-2513471;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:22801543}.
CC       Note=Recruited to DNA damage sites within 2 hours following UV
CC       irradiation. {ECO:0000269|PubMed:22801543}.
CC   -!- DEVELOPMENTAL STAGE: Expression is cell cycle-dependent, with highest
CC       levels in G2/M phase and lowest in S. {ECO:0000269|PubMed:22801543}.
CC   -!- SIMILARITY: Belongs to the DNA polymerase delta/II small subunit
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U21090; AAC50216.1; -; mRNA.
DR   EMBL; AF239710; AAG09763.1; -; Genomic_DNA.
DR   EMBL; AY116646; AAM51148.1; -; Genomic_DNA.
DR   EMBL; AK292347; BAF85036.1; -; mRNA.
DR   EMBL; AK312294; BAG35221.1; -; mRNA.
DR   EMBL; CH236960; EAL23767.1; -; Genomic_DNA.
DR   EMBL; CH471128; EAW61118.1; -; Genomic_DNA.
DR   EMBL; BC000459; AAH00459.1; -; mRNA.
DR   CCDS; CCDS5477.1; -.
DR   PIR; I38950; I38950.
DR   RefSeq; NP_001120690.1; NM_001127218.3.
DR   RefSeq; NP_001243808.1; NM_001256879.2.
DR   RefSeq; NP_006221.3; NM_006230.4.
DR   RefSeq; XP_024302570.1; XM_024446802.2.
DR   RefSeq; XP_047276455.1; XM_047420499.1.
DR   RefSeq; XP_047276456.1; XM_047420500.1.
DR   RefSeq; XP_047276457.1; XM_047420501.1.
DR   RefSeq; XP_054214436.1; XM_054358461.1.
DR   RefSeq; XP_054214437.1; XM_054358462.1.
DR   RefSeq; XP_054214438.1; XM_054358463.1.
DR   RefSeq; XP_054214439.1; XM_054358464.1.
DR   PDB; 3E0J; X-ray; 3.00 A; A/C/E/G=1-469.
DR   PDB; 6S1M; EM; 4.27 A; B=1-469.
DR   PDB; 6S1N; EM; 4.86 A; B=1-469.
DR   PDB; 6S1O; EM; 8.10 A; B=1-469.
DR   PDB; 6TNY; EM; 3.08 A; B=1-469.
DR   PDB; 6TNZ; EM; 4.05 A; B=1-469.
DR   PDB; 9EKB; EM; 3.65 A; B=1-469.
DR   PDBsum; 3E0J; -.
DR   PDBsum; 6S1M; -.
DR   PDBsum; 6S1N; -.
DR   PDBsum; 6S1O; -.
DR   PDBsum; 6TNY; -.
DR   PDBsum; 6TNZ; -.
DR   PDBsum; 9EKB; -.
DR   AlphaFoldDB; P49005; -.
DR   EMDB; EMD-10080; -.
DR   EMDB; EMD-10081; -.
DR   EMDB; EMD-10082; -.
DR   EMDB; EMD-10539; -.
DR   EMDB; EMD-10540; -.
DR   EMDB; EMD-48117; -.
DR   SMR; P49005; -.
DR   BioGRID; 111421; 77.
DR   ComplexPortal; CPX-2097; DNA polymerase delta complex.
DR   ComplexPortal; CPX-994; DNA polymerase zeta complex.
DR   CORUM; P49005; -.
DR   FunCoup; P49005; 1499.
DR   IntAct; P49005; 37.
DR   MINT; P49005; -.
DR   STRING; 9606.ENSP00000480186; -.
DR   ChEMBL; CHEMBL2363042; -.
DR   GlyCosmos; P49005; 1 site, 1 glycan.
DR   GlyGen; P49005; 4 sites, 2 N-linked glycans (2 sites), 1 O-linked glycan (1 site).
DR   iPTMnet; P49005; -.
DR   PhosphoSitePlus; P49005; -.
DR   BioMuta; POLD2; -.
DR   DMDM; 1352307; -.
DR   jPOST; P49005; -.
DR   MassIVE; P49005; -.
DR   PaxDb; 9606-ENSP00000480186; -.
DR   PeptideAtlas; P49005; -.
DR   ProteomicsDB; 55954; -.
DR   Pumba; P49005; -.
DR   Antibodypedia; 13259; 203 antibodies from 28 providers.
DR   DNASU; 5425; -.
DR   Ensembl; ENST00000406581.6; ENSP00000386105.2; ENSG00000106628.13.
DR   Ensembl; ENST00000418438.2; ENSP00000406702.2; ENSG00000106628.13.
DR   Ensembl; ENST00000452185.5; ENSP00000395231.1; ENSG00000106628.13.
DR   Ensembl; ENST00000610533.6; ENSP00000480186.2; ENSG00000106628.13.
DR   Ensembl; ENST00000698945.1; ENSP00000514051.1; ENSG00000106628.13.
DR   Ensembl; ENST00000698946.1; ENSP00000514052.1; ENSG00000106628.13.
DR   Ensembl; ENST00000698947.1; ENSP00000514053.1; ENSG00000106628.13.
DR   GeneID; 5425; -.
DR   KEGG; hsa:5425; -.
DR   MANE-Select; ENST00000610533.6; ENSP00000480186.2; NM_006230.4; NP_006221.3.
DR   UCSC; uc010kxz.5; human.
DR   AGR; HGNC:9176; -.
DR   CTD; 5425; -.
DR   DisGeNET; 5425; -.
DR   GeneCards; POLD2; -.
DR   HGNC; HGNC:9176; POLD2.
DR   HPA; ENSG00000106628; Low tissue specificity.
DR   MalaCards; POLD2; -.
DR   MIM; 600815; gene.
DR   OpenTargets; ENSG00000106628; -.
DR   VEuPathDB; HostDB:ENSG00000106628; -.
DR   eggNOG; KOG2732; Eukaryota.
DR   GeneTree; ENSGT00390000006780; -.
DR   HOGENOM; CLU_021763_0_0_1; -.
DR   InParanoid; P49005; -.
DR   OMA; HCILIGT; -.
DR   OrthoDB; 3763at2759; -.
DR   PAN-GO; P49005; 2 GO annotations based on evolutionary models.
DR   PhylomeDB; P49005; -.
DR   PathwayCommons; P49005; -.
DR   Reactome; R-HSA-110314; Recognition of DNA damage by PCNA-containing replication complex.
DR   Reactome; R-HSA-174411; Polymerase switching on the C-strand of the telomere.
DR   Reactome; R-HSA-174414; Processive synthesis on the C-strand of the telomere.
DR   Reactome; R-HSA-174417; Telomere C-strand (Lagging Strand) Synthesis.
DR   Reactome; R-HSA-174437; Removal of the Flap Intermediate from the C-strand.
DR   Reactome; R-HSA-5358565; Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha).
DR   Reactome; R-HSA-5358606; Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta).
DR   Reactome; R-HSA-5651801; PCNA-Dependent Long Patch Base Excision Repair.
DR   Reactome; R-HSA-5656169; Termination of translesion DNA synthesis.
DR   Reactome; R-HSA-5685942; HDR through Homologous Recombination (HRR).
DR   Reactome; R-HSA-5696397; Gap-filling DNA repair synthesis and ligation in GG-NER.
DR   Reactome; R-HSA-5696400; Dual Incision in GG-NER.
DR   Reactome; R-HSA-6782135; Dual incision in TC-NER.
DR   Reactome; R-HSA-6782210; Gap-filling DNA repair synthesis and ligation in TC-NER.
DR   Reactome; R-HSA-69091; Polymerase switching.
DR   Reactome; R-HSA-69166; Removal of the Flap Intermediate.
DR   Reactome; R-HSA-69183; Processive synthesis on the lagging strand.
DR   SignaLink; P49005; -.
DR   SIGNOR; P49005; -.
DR   BioGRID-ORCS; 5425; 775 hits in 1162 CRISPR screens.
DR   ChiTaRS; POLD2; human.
DR   EvolutionaryTrace; P49005; -.
DR   GeneWiki; POLD2; -.
DR   GenomeRNAi; 5425; -.
DR   Pharos; P49005; Tbio.
DR   PRO; PR:P49005; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; P49005; protein.
DR   Bgee; ENSG00000106628; Expressed in right uterine tube and 205 other cell types or tissues.
DR   ExpressionAtlas; P49005; baseline and differential.
DR   GO; GO:0043625; C:delta DNA polymerase complex; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0016035; C:zeta DNA polymerase complex; IDA:FlyBase.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   GO; GO:0071897; P:DNA biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0006260; P:DNA replication; TAS:ProtInc.
DR   GO; GO:0006271; P:DNA strand elongation involved in DNA replication; IBA:GO_Central.
DR   GO; GO:0006261; P:DNA-templated DNA replication; IDA:ComplexPortal.
DR   GO; GO:0042276; P:error-prone translesion synthesis; IDA:ComplexPortal.
DR   CDD; cd07387; MPP_PolD2_C; 1.
DR   DisProt; DP01807; -.
DR   FunFam; 3.60.21.50:FF:000001; DNA polymerase delta 2, accessory subunit; 1.
DR   FunFam; 3.60.21.50:FF:000008; DNA polymerase delta 2, accessory subunit; 1.
DR   FunFam; 2.40.50.430:FF:000001; DNA polymerase delta subunit 2; 1.
DR   Gene3D; 2.40.50.430; -; 1.
DR   Gene3D; 3.60.21.50; -; 1.
DR   IDEAL; IID00051; -.
DR   InterPro; IPR007185; DNA_pol_a/d/e_bsu.
DR   InterPro; IPR040663; DNA_pol_D_N.
DR   InterPro; IPR024826; DNA_pol_delta/II_ssu.
DR   InterPro; IPR041863; PolD2_C.
DR   PANTHER; PTHR10416; DNA POLYMERASE DELTA SUBUNIT 2; 1.
DR   PANTHER; PTHR10416:SF0; DNA POLYMERASE DELTA SUBUNIT 2; 1.
DR   Pfam; PF18018; DNA_pol_D_N; 1.
DR   Pfam; PF04042; DNA_pol_E_B; 1.
DR   neXtProt; NX_P49005; -.
DR   PharmGKB; PA33497; -.
DR   TreeFam; TF101073; -.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; DNA damage; DNA excision; DNA repair;
KW   DNA replication; Nucleus; Phosphoprotein; Proteomics identification;
KW   Reference proteome.
FT   CHAIN           1..469
FT                   /note="DNA polymerase delta subunit 2"
FT                   /id="PRO_0000096166"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0007744|PubMed:22223895,
FT                   ECO:0007744|PubMed:22814378"
FT   MOD_RES         15
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         257
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VARIANT         293
FT                   /note="D -> N (found in a patient with a syndromic combined
FT                   immunodeficiency disorder; uncertain significance; affects
FT                   protein stability; strongly reduced interaction with POLD1
FT                   and POLD3; in peripheral blood mononuclear cells, after
FT                   anti-CD3 and anti-CD28 stimulation, drastically reduced
FT                   protein expression levels, despite transcript levels
FT                   similar to that of wild-type controls; patient's cells also
FT                   show strongly decreased POLD1 and POLD3 protein levels; no
FT                   effect on DNA prolymerase activity, when tested in
FT                   transfected HEK293 cells)"
FT                   /evidence="ECO:0000269|PubMed:31449058"
FT                   /id="VAR_089632"
FT   VARIANT         303
FT                   /note="N -> S (in dbSNP:rs3087366)"
FT                   /evidence="ECO:0000269|Ref.3"
FT                   /id="VAR_014885"
FT   MUTAGEN         217
FT                   /note="L->W: Loss of POLD3-binding in a yeast two-hybrid
FT                   assay."
FT                   /evidence="ECO:0000269|PubMed:18818516"
FT   MUTAGEN         224
FT                   /note="G->W: Loss of POLD3-binding in a yeast two-hybrid
FT                   assay."
FT                   /evidence="ECO:0000269|PubMed:18818516"
FT   MUTAGEN         231
FT                   /note="E->W: Loss of POLD3-binding in a yeast two-hybrid
FT                   assay."
FT                   /evidence="ECO:0000269|PubMed:18818516"
FT   CONFLICT        271
FT                   /note="A -> T (in Ref. 4; BAG35221)"
FT                   /evidence="ECO:0000305"
FT   HELIX           2..7
FT                   /evidence="ECO:0007829|PDB:3E0J"
FT   STRAND          13..16
FT                   /evidence="ECO:0007829|PDB:3E0J"
FT   STRAND          32..34
FT                   /evidence="ECO:0007829|PDB:3E0J"
FT   HELIX           37..39
FT                   /evidence="ECO:0007829|PDB:3E0J"
FT   HELIX           55..72
FT                   /evidence="ECO:0007829|PDB:3E0J"
FT   STRAND          82..84
FT                   /evidence="ECO:0007829|PDB:3E0J"
FT   STRAND          91..100
FT                   /evidence="ECO:0007829|PDB:3E0J"
FT   STRAND          132..136
FT                   /evidence="ECO:0007829|PDB:3E0J"
FT   STRAND          141..147
FT                   /evidence="ECO:0007829|PDB:3E0J"
FT   TURN            150..152
FT                   /evidence="ECO:0007829|PDB:3E0J"
FT   STRAND          158..165
FT                   /evidence="ECO:0007829|PDB:3E0J"
FT   STRAND          169..177
FT                   /evidence="ECO:0007829|PDB:3E0J"
FT   STRAND          195..199
FT                   /evidence="ECO:0007829|PDB:3E0J"
FT   HELIX           209..223
FT                   /evidence="ECO:0007829|PDB:3E0J"
FT   HELIX           229..235
FT                   /evidence="ECO:0007829|PDB:3E0J"
FT   STRAND          238..245
FT                   /evidence="ECO:0007829|PDB:3E0J"
FT   HELIX           265..287
FT                   /evidence="ECO:0007829|PDB:3E0J"
FT   STRAND          292..295
FT                   /evidence="ECO:0007829|PDB:3E0J"
FT   STRAND          300..302
FT                   /evidence="ECO:0007829|PDB:3E0J"
FT   STRAND          304..307
FT                   /evidence="ECO:0007829|PDB:3E0J"
FT   HELIX           313..315
FT                   /evidence="ECO:0007829|PDB:6TNY"
FT   HELIX           317..320
FT                   /evidence="ECO:0007829|PDB:3E0J"
FT   STRAND          325..327
FT                   /evidence="ECO:0007829|PDB:3E0J"
FT   STRAND          330..336
FT                   /evidence="ECO:0007829|PDB:3E0J"
FT   STRAND          339..343
FT                   /evidence="ECO:0007829|PDB:3E0J"
FT   HELIX           347..355
FT                   /evidence="ECO:0007829|PDB:3E0J"
FT   HELIX           361..370
FT                   /evidence="ECO:0007829|PDB:3E0J"
FT   TURN            378..380
FT                   /evidence="ECO:0007829|PDB:6TNY"
FT   STRAND          400..409
FT                   /evidence="ECO:0007829|PDB:3E0J"
FT   STRAND          411..416
FT                   /evidence="ECO:0007829|PDB:3E0J"
FT   STRAND          418..420
FT                   /evidence="ECO:0007829|PDB:6TNY"
FT   STRAND          422..429
FT                   /evidence="ECO:0007829|PDB:3E0J"
FT   HELIX           431..434
FT                   /evidence="ECO:0007829|PDB:3E0J"
FT   STRAND          436..441
FT                   /evidence="ECO:0007829|PDB:3E0J"
FT   TURN            442..445
FT                   /evidence="ECO:0007829|PDB:3E0J"
FT   STRAND          449..454
FT                   /evidence="ECO:0007829|PDB:3E0J"
FT   TURN            460..462
FT                   /evidence="ECO:0007829|PDB:3E0J"
SQ   SEQUENCE   469 AA;  51289 MW;  389EF730999755AC CRC64;
     MFSEQAAQRA HTLLSPPSAN NATFARVPVA TYTNSSQPFR LGERSFSRQY AHIYATRLIQ
     MRPFLENRAQ QHWGSGVGVK KLCELQPEEK CCVVGTLFKA MPLQPSILRE VSEEHNLLPQ
     PPRSKYIHPD DELVLEDELQ RIKLKGTIDV SKLVTGTVLA VFGSVRDDGK FLVEDYCFAD
     LAPQKPAPPL DTDRFVLLVS GLGLGGGGGE SLLGTQLLVD VVTGQLGDEG EQCSAAHVSR
     VILAGNLLSH STQSRDSINK AKYLTKKTQA ASVEAVKMLD EILLQLSASV PVDVMPGEFD
     PTNYTLPQQP LHPCMFPLAT AYSTLQLVTN PYQATIDGVR FLGTSGQNVS DIFRYSSMED
     HLEILEWTLR VRHISPTAPD TLGCYPFYKT DPFIFPECPH VYFCGNTPSF GSKIIRGPED
     QTVLLVTVPD FSATQTACLV NLRSLACQPI SFSGFGAEDD DLGGLGLGP
//
